|
1
|
Ansari D, Tingstedt B, Andersson B,
Holmquist F, Sturesson C, Williamsson C, Sasor A, Borg D, Bauden M
and Andersson R: Pancreatic cancer: Yesterday, today and tomorrow.
Future Oncol. 12:1929–1946. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chari ST, Kelly K, Hollingsworth MA,
Thayer SP, Ahlquist DA, Andersen DK, Batra SK, Brentnall TA, Canto
M, Cleeter DF, et al: Early detection of sporadic pancreatic
cancer: Summative review. Pancreas. 44:693–712. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lehen'kyi V, Raphaël M and Prevarskaya N:
The role of the TRPV6 channel in cancer. J Physiol. 590:1369–1376.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wissenbach U, Niemeyer B, Himmerkus N,
Fixemer T, Bonkhoff H and Flockerzi V: TRPV6 and prostate cancer:
Cancer growth beyond the prostate correlates with increased TRPV6
Ca2+ channel expression. Biochem Biophys Res Commun.
322:1359–1363. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Giusti L, Cetani F, Da Valle Y, Pardi E,
Ciregia F, Donadio E, Gargini C, Piano I, Borsari S, Jaber A, et
al: First evidence of TRPV5 and TRPV6 channels in human parathyroid
glands: Possible involvement in neoplastic transformation. J Cell
Mol Med. 18:1944–1952. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ouadid-Ahidouch H, Dhennin-Duthille I,
Gautier M, Sevestre H and Ahidouch A: TRP calcium channel and
breast cancer: Expression, role and correlation with clinical
parameters. Bull Cancer. 99:655–664. 2012.(In French). PubMed/NCBI
|
|
7
|
Zhang SS, Xie X, Wen J, Luo KJ, Liu QW,
Yang H, Hu Y and Fu JH: TRPV6 plays a new role in predicting
survival of patients with esophageal squamous cell carcinoma. Diagn
Pathol. 11:142016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fan H, Shen YX and Yuan YF: Expression and
prognostic roles of TRPV5 and TRPV6 in non-small cell lung cancer
after curative resection. Asian Pac J Cancer Prev. 15:2559–2563.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu Y, Miyamoto T, Li K, Nakagomi H, Sawada
N, Kira S, Kobayashi H, Zakohji H, Tsuchida T, Fukazawa M, et al:
Decreased expression of the epithelial Ca2+ channel
TRPV5 and TRPV6 in human renal cell carcinoma associated with
vitamin D receptor. J Urol. 186:2419–2425. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Uemura T, Shepherd S, Ackerman L, Jan LY
and Jan YN: numb, a gene required in determination of cell fate
during sensory organ formation in Drosophila embryos. Cell.
58:349–360. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gulino A, Di Marcotullio L and Screpanti
I: The multiple functions of Numb. Exp Cell Res. 316:900–906. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim SY, Hong C, Wie J, Kim E, Kim BJ, Ha
K, Cho NH, Kim IG, Jeon JH and So I: Reciprocal positive regulation
between TRPV6 and NUMB in PTEN-deficient prostate cancer cells.
Biochem Biophys Res Commun. 447:192–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim SY, Yang D, Myeong J, Ha K, Kim SH,
Park EJ, Kim IG, Cho NH, Lee KP, Jeon JH, et al: Regulation of
calcium influx and signaling pathway in cancer cells via
TRPV6-Numb1 interaction. Cell Calcium. 53:102–111. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yamasawa K, Nio Y, Dong M, Yamaguchi K and
Itakura M: Clinicopathological significance of abnormalities in
Gadd45 expression and its relationship to p53 in human pancreatic
cancer. Clin Cancer Res. 8:2563–2569. 2002.PubMed/NCBI
|
|
15
|
Masunaga R, Kohno H, Dhar DK, Ohno S,
Shibakita M, Kinugasa S, Yoshimura H, Tachibana M, Kubota H and
Nagasue N: Cyclooxygenase-2 expression correlates with tumor
neovascularization and prognosis in human colorectal carcinoma
patients. Clin Cancer Res. 6:4064–4068. 2000.PubMed/NCBI
|
|
16
|
Sheng W, Dong M, Zhou J, Li X, Liu Q, Dong
Q and Li F: The relationship and clinicopathological significance
of Numb, MDM2 and p53 expression in human pancreatic cancer.
Zhonghua Wai Ke Za Zhi. 52:675–681. 2014.(In Chinese). PubMed/NCBI
|
|
17
|
Wissenbach U, Niemeyer BA, Fixemer T,
Schneidewind A, Trost C, Cavalie A, Reus K, Meese E, Bonkhoff H and
Flockerzi V: Expression of CaT-like, a novel calcium-selective
channel, correlates with the malignancy of prostate cancer. J Biol
Chem. 276:19461–19468. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dhennin-Duthille I, Gautier M, Faouzi M,
Guilbert A, Brevet M, Vaudry D, Ahidouch A, Sevestre H and
Ouadid-Ahidouch H: High expression of transient receptor potential
channels in human breast cancer epithelial cells and tissues:
Correlation with pathological parameters. Cell Physiol Biochem.
28:813–822. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bartik L, Whitfield GK, Kaczmarska M,
Lowmiller CL, Moffet EW, Furmick JK, Hernandez Z, Haussler CA,
Haussler MR and Jurutka PW: Curcumin: A novel nutritionally derived
ligand of the vitamin D receptor with implications for colon cancer
chemoprevention. J Nutr Biochem. 21:1153–1161. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chow J, Norng M, Zhang J and Chai J: TRPV6
mediates capsaicin-induced apoptosis in gastric cancer cells -
Mechanisms behind a possible new ‘hot’ cancer treatment. Biochim
Biophys Acta. 1773:565–576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Raphaël M, Lehen'kyi V, Vandenberghe M,
Beck B, Khalimonchyk S, Vanden Abeele F, Farsetti L, Germain E,
Bokhobza A, Mihalache A, et al: TRPV6 calcium channel translocates
to the plasma membrane via Orai1-mediated mechanism and controls
cancer cell survival. Proc Natl Acad Sci USA. 111:pp. E3870–E3879.
2014; View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schwarz EC, Wissenbach U, Niemeyer BA,
Strauss B, Philipp SE, Flockerzi V and Hoth M: TRPV6 potentiates
calcium-dependent cell proliferation. Cell Calcium. 39:163–173.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vanden Abeele F, Roudbaraki M, Shuba Y,
Skryma R and Prevarskaya N: Store-operated Ca2+ current
in prostate cancer epithelial cells. Role of endogenous
Ca2+ transporter type 1. J Biol Chem. 278:15381–15389.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tauzin S, Chaigne-Delalande B, Selva E,
Khadra N, Daburon S, Contin-Bordes C, Blanco P, Le Seyec J, Ducret
T, Counillon L, et al: The naturally processed CD95L elicits a
c-yes/calcium/PI3K-driven cell migration pathway. PLoS Biol.
9:e10010902011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peleg S, Sellin JH, Wang Y, Freeman MR and
Umar S: Suppression of aberrant transient receptor potential cation
channel, subfamily V, member 6 expression in hyperproliferative
colonic crypts by dietary calcium. Am J Physiol Gastrointest Liver
Physiol. 299:G593–G601. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lehen'kyi V, Flourakis M, Skryma R and
Prevarskaya N: TRPV6 channel controls prostate cancer cell
proliferation via Ca(2+)/NFAT-dependent pathways. Oncogene.
26:7380–7385. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Russo S, Ammori J, Eads J and Dorth J: The
role of neoadjuvant therapy in pancreatic cancer: A review. Future
Oncol. 12:669–685. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ettrich TJ, Perkhofer L, von Wichert G,
Gress TM, Michl P, Hebart HF, Büchner-Steudel P, Geissler M, Muche
R, Danner B, et al: DocOx (AIO-PK0106): A phase II trial of
docetaxel and oxaliplatin as a second line systemic therapy in
patients with advanced pancreatic ductal adenocarcinoma. BMC
Cancer. 16:212016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rajan S, Choi M, Nguyen QT, Ye H, Liu W,
Toh HT, Kang C, Kamariah N, Li C, Huang H, et al: Structural
transition in Bcl-xL and its potential association with
mitochondrial calcium ion transport. Sci Rep. 5:106092015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Luna-Vargas MP and Chipuk JE: The deadly
landscape of pro-apoptotic BCL-2 proteins in the outer
mitochondrial membrane. FEBS J. 283:2676–2689. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Serrano-Gomez SJ, Maziveyi M and Alahari
SK: Regulation of epithelial-mesenchymal transition through
epigenetic and post-translational modifications. Mol Cancer.
15:182016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Verma S, Kesh K, Gupta A and Swarnakar S:
An overview of matrix metalloproteinase 9 polymorphism and gastric
cancer risk. Asian Pac J Cancer Prev. 16:7393–7400. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sheng W, Dong M, Zhou J, Li X, Liu Q, Dong
Q and Li F: Cooperation among Numb, MDM2 and p53 in the development
and progression of pancreatic cancer. Cell Tissue Res. 354:521–532.
2013. View Article : Google Scholar : PubMed/NCBI
|
